Secretoneurin, substance P and neuropeptide y in the oxygen-induced retinopathy in C57Bl/6N mice

Peptides

Volumn 37, Issue 2, 2012, Pages 252-257

  Schmid, Eduard ^a   Nogalo, Marina ^a   Bechrakis, Nikolaos E ^a   Fischer Colbrie, Reiner ^a   Tasan, Ramon ^a   Sperk, Günther ^a   Theurl, Markus ^a   Beer, Arno G E ^a   Kirchmair, Rudolf ^a   Herzog, Herbert ^b   Troger, Josef ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Mice; Neuropeptide Y; Oxygen induced retinopathy; Secretoneurin; Substance P

Indexed keywords

CD31 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; NEUROPEPTIDE Y; NEUROPEPTIDE Y2 RECEPTOR; OXYGEN; SECRETONEURIN; SUBSTANCE P; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPEROXIA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETINOPATHY;

ANIMALS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPEROXIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDE Y; NEUROPEPTIDES; RADIOIMMUNOASSAY; RETINA; RETINAL NEOVASCULARIZATION; SECRETOGRANIN II; SUBSTANCE P;

ANIMALIA; MUS;

EID: 84865315520     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.07.024     Document Type: Article

References (58)

1. T. Alon, I. Hemo, A. Itin, J. Pe'er, J. Stone, and E. Keshet Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity Nat Med 1 1995 1024 1028
2. R. Bellmann, R. Widmann, C. Olenik, D.K. Meyer, D. Maas, and J. Marksteiner Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures J Neurochem 56 1991 525 530
3. N. Brecha, D. Johnson, J. Bolz, S. Sharma, J.G. Parnavelas, and A.R. Lieberman Substance P-immunoreactive retinal ganglion cells and their central axon terminals in the rabbit Nature 327 1987 155 158
4. D.M. Caruso, M.T. Owczarzak, and R.G. Pourcho Colocalization of substance P and GABA in retinal ganglion cells: a computer-assisted visualization Vis Neurosci 5 1990 389 394
5. N. Cuenca, J. De Juan, and H. Kolb Substance P-immunoreactive neurons in the human retina J Comp Neurol 356 1995 491 504
6. E. Dick, and R.F. Miller Peptides influence retinal ganglion cells Neurosci Lett 26 1981 131 135
7. M. Egger, W. Schgoer, A.G.E. Beer, J. Jeschke, J. Leierer, and M. Theurl Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1alpha- and basic FGF-dependent pathway in muscle cells FASEB J 21 2007 2906 2917
8. D. Ehrlich, K.T. Keyser, and H.J. Karten Distribution of substance P-like immunoreactive retinal ganglion cells and their pattern of termination in the optic tectum of chick (Gallus gallus) J Comp Neurol 266 1987 220 233
9. A.J. Ekstrand, R. Cao, M. Bjorndahl, S. Nystrom, A-C. Jonsson-Rylander, and H. Hassani Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing Proc Natl Acad Sci USA 100 2003 6033 6038
10. S.G. Elner, V.M. Elner, A. Yoshida, R.D. Dick, and G.J. Brewer Effects of tetrathiomolybdate in a mouse model of retinal neovascularization Invest Ophthalmol Vis Sci 46 2005 299 303
11. N. Ferrara Vascular endothelial growth factor and the regulation of angiogenesis Recent Prog Horm Res 55 2000 15 35 discussion 35-16
12. G. Gao, Y. Li, S. Gee, A. Dudley, J. Fant, and C. Crosson Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5 J Biol Chem 277 2002 9492 9497
13. P. Geisen, L.J. Peterson, D. Martiniuk, A. Uppal, Y. Saito, and M.E. Hartnett Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity Mol Vis 14 2008 345 357
14. G. Ghersi, W. Chen, E.W. Lee, and Z. Zukowska Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding Peptides 22 2001 453 458
15. R.D. Glickman, A.R. Adolph, and J.E. Dowling Inner plexiform circuits in the carp retina: effects of cholinergic agonists, GABA, and substance P on the ganglion cells Brain Res 234 1982 81 99
16. T. Hökfelt, D. Stanic, S.D. Sanford, J.C. Gatlin, I. Nilsson, and G. Paratcha NPY and its involvement in axon guidance, neurogenesis, and feeding Nutrition 24 2008 860 868
17. D.E. Hu, Y. Hori, and T.P. Fan Interleukin-8 stimulates angiogenesis in rats Inflammation 17 1993 135 143
18. T. Karl, L. Duffy, and H. Herzog Behavioural profile of a new mouse model for NPY deficiency Eur J Neurosci 28 2008 173 180
19. R. Kirchmair, M. Egger, D.H. Walter, W. Eisterer, A. Niederwanger, and E. Woell Secretoneurin, an angiogenic neuropeptide, induces postnatal vasculogenesis Circulation 110 2004 1121 1127
20. R. Kirchmair, R. Gander, M. Egger, A. Hanley, M. Silver, and A. Ritsch The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo Circulation 109 2004 777 783
21. R. Kirchmair, R. Hogue-Angeletti, J. Gutierrez, R. Fischer-Colbrie, and H. Winkler Secretoneurin - a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C) Neuroscience 53 1993 359 365
22. J. Kitlinska, E.W. Lee, S. Movafagh, J. Pons, and Z. Zukowska Neuropeptide Y-induced angiogenesis in aging Peptides 23 2002 71 77
23. H. Kohara, S. Tajima, M. Yamamoto, and Y. Tabata Angiogenesis induced by controlled release of neuropeptide substance P Biomaterials 31 2010 8617 8625
24. M. Koulu, S. Movafagh, J. Tuohimaa, U. Jaakkola, J. Kallio, and U. Pesonen Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization Ann Med 36 2004 232 240
25. E.W. Lee, D.S. Grant, S. Movafagh, and Z. Zukowska Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice Peptides 24 2003 99 106
26. E.W. Lee, M. Michalkiewicz, J. Kitlinska, I. Kalezic, H. Switalska, and P. Yoo Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles J Clin Invest 111 2003 1853 1862
27. H.B. Li, and D.M. Lam Localization of neuropeptide-immunoreactive neurons in the human retina Brain Res 522 1990 30 36
28. C. Lu, L. Everhart, J. Tilan, L. Kuo, C-C.J. Sun, and R.B. Munivenkatappa Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy Oncogene 29 2010 5630 5642
29. J.E. Maggio Tachykinins Annu Rev Neurosci 11 1988 13 28
30. R. Mentlein, P. Dahms, D. Grandt, and R. Krüger Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV Regul Peptides 49 1993 133 144
31. M. Otsuka, and K. Yoshioka Neurotransmitter functions of mammalian tachykinins Physiol Rev 73 1993 229 308
32. B. Overdick, R. Kirchmair, J. Marksteiner, R. Fischer-Colbrie, J. Troger, and H. Winkler Presence and distribution of a new neuropeptide, secretoneurin, in human retina Peptides 17 1996 1 4
33. L. Pelletier, R. Angonin, J. Regnard, D. Fellmann, and P. Charbord Human bone marrow angiogenesis: in vitro modulation by substance P and neurokinin A Br J Haematol 119 2002 1083 1089
34. E.A. Pierce, R.L. Avery, E.D. Foley, L.P. Aiello, and L.E. Smith Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization Proc Natl Acad Sci USA 92 1995 905 909
35. E.A. Pierce, E.D. Foley, and L.E. Smith Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity Arch Ophthalmol 114 1996 1219 1228
36. W. Schgoer, M. Theurl, J. Jeschke, A.G.E. Beer, K. Albrecht, and R. Gander Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism Circ Res 105 2009 994 1002
37. H.C. Seegers, V.C. Hood, B.L. Kidd, S.C. Cruwys, and D.A. Walsh Enhancement of angiogenesis by endogenous substance P release and neurokinin-1 receptors during neurogenic inflammation J Pharmacol Exp Ther 306 2003 8 12
38. C. Severini, G. Improta, G. Falconieri-Erspamer, S. Salvadori, and V. Erspamer The tachykinin peptide family Pharmacol Rev 54 2002 285 322
39. W-C. Shyu, S-Z. Lin, M-F. Chiang, D-C. Chen, C-Y. Su, and H-J. Wang Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke J Clin Invest 118 2008 133 148
40. A.P. Silva, C. Cavadas, and E. Grouzmann Neuropeptide Y and its receptors as potential therapeutic drug targets Clin Chim Acta 326 2002 3 25
41. L. Smith, E. Wesolowski, A. Mclellan, S. Kostyk, R. D'amato, and R. Sullivan Oxygen-induced retinopathy in the mouse Invest Ophthalmol Vis Sci 35 1994 101
42. A. Stahl, K.M. Connor, P. Sapieha, J. Chen, R.J. Dennison, and N.M. Krah The mouse retina as an angiogenesis model Invest Ophthalmol Vis Sci 51 2010 2813 2826
43. J. Stone, T. Chan-Ling, J. Pe'er, A. Itin, H. Gnessin, and E. Keshet Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity Invest Ophthalmol Vis Sci 37 1996 290 299
44. K. Takatsuji, J.J. Miguel-Hidalgo, and M. Tohyama Substance P-immunoreactive innervation from the retina to the suprachiasmatic nucleus in the rat Brain Res 568 1991 223 229
45. K. Tatemoto, M. Carlquist, and V. Mutt Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide Nature 296 1982 659 660
46. K. Tornqvist, and B. Ehinger Peptide immunoreactive neurons in the human retina Invest Ophthalmol Vis Sci 29 1988 680 686
47. D. Verma, R.O. Tasan, H. Herzog, and G. Sperk NPY controls fear conditioning and fear extinction by combined action on YY(1) and Y(2) receptors Br J Pharmacol 166 2012 1461 1473
48. C.J. Wiedermann Secretoneurin: a functional neuropeptide in health and disease Peptides 21 2000 1289 1298
49. C.J. Wiedermann, B. Auer, B. Sitte, N. Reinisch, P. Schratzberger, and C.M. Kähler Induction of endothelial cell differentiation into capillary-like structures by substance P Eur J Pharmacol 298 1996 335 338
50. H.Z. Yoon, Y. Yan, Y. Geng, and R.D. Higgins Neuropeptide Y expression in a mouse model of oxygen-induced retinopathy Clin Experiment Ophthalmol 30 2002 424 429
51. R.A. Zalutsky, and R.F. Miller The physiology of substance P in the rabbit retina J Neurosci 10 1990 394 402
52. M. Ziche, L. Morbidelli, P. Geppetti, C.A. Maggi, and P. Dolara Substance P induces migration of capillary endothelial cells: a novel NK-1 selective receptor mediated activity Life Sci 48 1991 PL7 PL11
53. M. Ziche, L. Morbidelli, E. Masini, S. Amerini, H.J. Granger, and C.A. Maggi Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P J Clin Invest 94 1994 2036 2044
54. M. Ziche, L. Morbidelli, M. Pacini, P. Geppetti, G. Alessandri, and C.A. Maggi Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells Microvasc Res 40 1990 264 278
55. M. Ziche, A. Parenti, F. Ledda, P. Dell'Era, H.J. Granger, and C.A. Maggi Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF Circ Res 80 1997 845 852
56. Z. Zukowska, D.S. Grant, and E.W. Lee Neuropeptide Y: a novel mechanism for ischemic angiogenesis Trends Cardiovasc Med 13 2003 86 92
57. Z. Zukowska-Grojec, E. Karwatowska-Prokopczuk, T.A. Fisher, and H. Ji Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors Regul Peptides 7 1998 5 76 231-8
58. Z. Zukowska-Grojec, E. Karwatowska-Prokopczuk, W. Rose, J. Rone, S. Movafagh, and H. Ji Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium Circ Res 83 1998 187 195